Ås, Norway

Ragnar Flengsrud

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Hepmarin as. Active years: 2009.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ragnar Flengsrud: Innovator in Anticoagulant Research

Introduction

Ragnar Flengsrud is a notable inventor based in Ås, Norway. He has made significant contributions to the field of biomedical research, particularly in the development of anticoagulant substances derived from fish. His innovative work has the potential to impact medical treatments and improve patient outcomes.

Latest Patents

Flengsrud holds a patent for "Glycosaminoglycan anticoagulants derived from fish." This invention provides anticoagulant piscine gill glucosaminoglycans, which are high-affinity anticoagulant substances extractable from salmon guts, skin, tail, or gills, along with their salts and derivatives. This patent represents a significant advancement in the field of anticoagulant research.

Career Highlights

Ragnar Flengsrud has dedicated his career to exploring the therapeutic potential of natural substances. His work at Hepmarin AS has allowed him to focus on the extraction and application of glycosaminoglycans for medical use. His research is paving the way for new anticoagulant therapies that could benefit patients worldwide.

Collaborations

Flengsrud has collaborated with notable colleagues, including Per Olav Skjervold and Ole Rasmus Ødegaard. These partnerships have fostered a collaborative environment that enhances the research and development of innovative medical solutions.

Conclusion

Ragnar Flengsrud is a pioneering inventor whose work in anticoagulant research is making waves in the biomedical field. His contributions, particularly through his patent on glycosaminoglycan anticoagulants, highlight the importance of innovation in healthcare. His ongoing research and collaborations promise to lead to significant advancements in medical treatments.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…